Larsen A, Horton J, Howland C
Clin Rheumatol. 1984 Mar;3 Suppl 1:97-104. doi: 10.1007/BF03342627.
X-rays from patients in comparative studies of auranofin and parenteral gold were obtained before and during treatment, and analysed using a modification of the method of Larsen. One hundred and nineteen auranofin-treated and 113 parenteral gold-treated patients contributed data, which were analysed for changes from 0-6 months, 0-12 months and from 0-6 and 12 months. Progression of erosive processes and of joint grade occurred with both treatments, but the proportion of patients with progression in the first six months was greater with auranofin treatment. However, there was evidence that both treatments produced slowing of the erosive process during the second six months of treatment.
在金诺芬与肠胃外金制剂的对比研究中,于治疗前及治疗期间获取了患者的X光片,并采用对拉森方法的一种改良方法进行分析。119名接受金诺芬治疗的患者和113名接受肠胃外金制剂治疗的患者提供了数据,对这些数据分析了0至6个月、0至12个月以及0至6个月和12个月期间的变化情况。两种治疗方式下均出现了侵蚀性病变过程和关节分级的进展,但在前六个月出现进展的患者比例在金诺芬治疗组中更高。然而,有证据表明两种治疗方式在治疗的第二个六个月期间均使侵蚀性病变过程减缓。